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S U M M A R Y
We report a case of rapidly progressive vision loss in a young woman with a history of injection drug use.
Subsequent enucleation of the affected eye was done and Bacillus cereus grew on tissue culture. B. cereus is
a rare cause of endogenous endophthalmitis due to hematogenous seeding of the vitreous in the setting of
injection drug use.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Bacillus cereus eye infections are frequently associated with
traumatic eye injuries and post-operative complications. Rarely,
endogenous B. cereus endophthalmitis may develop as a result of
hematogenous seeding due to intravenous drug use. In this paper,
we describe the case of a young woman with fulminant B. cereus
endophthalmitis/panophthalmitis in association with intravenous
methamphetamine use. Despite early and aggressive treatment
with broad-spectrum intravenous antibiotics she progressed to
complete vision loss necessitating enucleation to prevent intra-
cranial spread of infection. B. cereus endopthalmitis should be
considered in the differential diagnosis when evaluating intrave-
nous drug users with visual symptoms.
2. Case report
An 18-year-old Caucasian woman with a history of intravenous
drug abuse presented with a severe left-sided frontal headache
followed by left-sided peri-orbital pain, redness, and swelling for 1
week. Symptoms began as a mild headache, which progressed to
swelling and redness of the left eye, decreased visual acuity, and* Corresponding author.
E-mail address: nilaykumar83@gmail.com (N. Kumar).
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license (http://creativecommons.org/licenses/by-nc-nd/3.0/).severe pain on eye movement within 2–3 days. Evaluation at
another facility 2 days prior to presentation was suggestive of
endophthalmitis, and treatment with intravenous vancomycin and
piperacillin–tazobactam was initiated. In the following 48 h her
symptoms progressed relentlessly to complete vision loss in the
left eye, prompting transfer to our tertiary medical center. She
smoked marijuana and used methamphetamines, occasionally
sharing needles for injection drug use. The most recent episode of
injection drug use was 1 week prior to admission.
On examination, there was left eye proptosis with peri-orbital
swelling, erythema, and exquisite tenderness to palpation. There
was no light perception in the affected eye. Marked sinus
tenderness was noted. Routine laboratory tests showed a white
blood cell count of 18  109/l with 86% neutrophils; serology for
HIV 1 and 2 was negative. A tomography scan of the orbits showed
proptosis and enlargement of the left globe, with circumferential
scleral enhancement (Figures 1 and 2). There was no evidence of
cavernous sinus thrombosis. Initial differential diagnoses included
polymicrobial aerobic/anaerobic infection, staphylococcal/strep-
tococcal infection, mucormycosis, and invasive aspergillosis.
Intravenous vancomycin and piperacillin–tazobactam were
continued. An emergent ophthalmology consult was obtained.
Given the progressive nature of the infection despite antibiotics
and the potential for intracranial spread of the infection, an urgent
enucleation with peri-orbital tissue debridement was performed.
Gram stain of the ocular tissue showed abundant Gram-positiveciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 2. Horizontal contrast-enhanced computed tomography image showing
signiﬁcant enlargement of the left globe along with diffuse contrast enhancement of
the sclera suggestive of panophthalmitis.
Figure 1. Coronal reconstructed contrast-enhanced computed tomography image
showing signiﬁcant enlargement of the left globe along with diffuse contrast
enhancement of the sclera suggestive of panophthalmitis.
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of treatment with intravenous vancomycin and was discharged on
oral ciproﬂoxacin to complete 6 weeks of antibiotic treatment. She
was doing well at follow-up 3 months after discharge.
3. Discussion
Infectious complications are common among injection drug
users (IDUs). Staphylococcus aureus, Streptococcus, and Gram-
negative rods are commonly implicated in such infections. An
increasing number of reports have described Bacillus species as
pathogens in IDUs.
B. cereus is a ubiquitous, motile, endospore-forming, Gram-
positive rod. It is perhaps best known as a cause of food poisoning
associated with the consumption of stale fried rice and is often
regarded to be a ‘non-pathogenic’ contaminant when isolated in
other settings. Rare cases of B. cereus meningitis, endocarditis, and
septicemia have been reported in high-risk patients with acute
leukemia and other immunodeﬁciency states.1
Exogenous endophthalmitis due to B. cereus is relatively
common in the setting of traumatic globe injuries,1 however
reports of endogenous endophthalmitis due to B. cereus in
association with injection drug use are rare.2–4 These infections
are extremely fulminant with rapid progression to panophthalmi-
tis and loss of light perception within hours of intraocular
inoculation. The pathogenesis of ocular infections in IDUs involves
transient bacteremia and lodging of infectious emboli in the retinal
and ciliary arterioles.
B. cereus is a highly virulent organism due to the production of
enzymes lecithin, hemolysins, and phospholipase C, resulting in
rapid tissue destruction.1 Expedited treatment with intravenousvancomycin, aminoglycosides, or ﬂuoroquinolones is the treat-
ment of choice.1–4 Systemic antibiotics are indicated in all cases of
endogenous endophthalmitis due to B. cereus. In cases of
exogenous B. cereus endophthalmitis, as in the case of traumatic
globe injuries, intravitreal antibiotics including vancomycin and
ceftazidime are indicated with or without vitrectomy.5
Despite adequate treatment, outcomes are typically poor,
resulting in complete vision loss, phthisis bulbi, or enucleation.
There were 35 cases of B. cereus eye infection reported in the 20th
century, of which 70% resulted in vision loss due to enucleation.1
In conclusion, we have described a case of fulminant B. cereus
panophthalmitis with irreversible vision loss associated with
injection drug use. Internists and infectious disease specialists
should remain cognizant of ocular B. cereus infections when
evaluating IDUs with retro-orbital headaches, eye pain, or
decreased visual acuity.
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